港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

英派藥業-B

37.000

-0.680-1.80%

成交量：25.22萬

成交額：930.26萬

市值：104.51億

市盈率：-25.68

高：37.480

開：36.800

低：36.100

收：37.680

52周最高：47.980

52周最低：28.200

股本：2.82億

香港流通股本：2.82億

量比：0.68

換手率：0.09%

股息：- -

股息率：- -

每股收益(LYR):-1.441

淨資產收益率：--

總資產收益率：-40.35%

市淨率：-9.43

市盈率(LYR):-25.68

市銷率: 236.16

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

《大行》高盛列出具有納入南向交易潛力半新股(表)

阿斯达克财经

英派藥業-B：6月10日因超額配股權行使發行629.64萬股H股，涉資約1.27億港元

英派藥業-B(07630)因超額配股權獲行使而發行629.64萬股H股

英派藥業-B(07630)：悉數行使超額配股權、穩定價格行動及穩定價格期結束

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/07630"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"07630","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07630\",,,,,undefined,":{"symbol":"07630","market":"HK","secType":"STK","nameCN":"英派藥業-B","latestPrice":37,"timestamp":1781770087306,"preClose":37.68,"halted":0,"volume":252200,"delay":0,"changeRate":-0.01804670912951167,"floatShares":282461530,"shares":282461530,"eps":-1.440772,"marketStatus":"已收盤","change":-0.68,"latestTime":"06-18 16:08:07","open":36.8,"high":37.48,"low":36.1,"amount":9302636,"amplitude":0.036624,"askPrice":37.02,"askSize":200,"bidPrice":37,"bidSize":14600,"shortable":0,"etf":0,"ttmEps":-1.16,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1782091800000},"marketStatusCode":5,"adr":0,"listingDate":1778601600000,"exchange":"SEHK","adjPreClose":37.68,"openAndCloseTimeList":[[1781746200000,1781755200000],[1781758800000,1781769600000]],"volumeRatio":0.676938,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07630\",,,,,undefined,":{"symbol":"07630","floatShares":282461530,"roa":"-40.35%","roe":"--","lyrEps":-1.440772,"volumeRatio":0.676938,"shares":282461530,"dividePrice":0,"high":37.48,"amplitude":0.036624,"preClose":37.68,"low":36.1,"week52Low":28.2,"pbRate":"-9.43","psRate":"236.16","week52High":47.98,"institutionHeld":0,"latestPrice":37,"committee":0.972973,"eps":-1.440772,"divideRate":0,"volume":252200,"delay":0,"ttmEps":-1.16,"open":36.8,"prevYearClose":20.1,"prevWeekClose":36.4,"prevMonthClose":39.9,"prevQuarterClose":20.1,"fiveDayClose":37,"twentyDayClose":37.44,"sixtyDayClose":20.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/07630\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"07630\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"07630\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/07630\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"07630","date":"2026-06-17","current":-31.896552,"percent":0.56,"low":-34.323153,"twenty":-32.317058,"median":-30.409488,"eighty":-29.732748,"high":-16.800385,"avg":-30.309008,"sd":3.194878,"marketCap":10405902098},"quantilePoints":[{"date":"2026-05-15","current":-32.36994,"twenty":-32.973318,"median":-32.357426,"eighty":-26.127101,"marketCap":11057651805},{"date":"2026-05-22","current":-30.548005,"twenty":-32.354923,"median":-30.958502,"eighty":-28.393426,"marketCap":10411425401},{"date":"2026-05-29","current":-32.218614,"twenty":-32.294393,"median":-30.958502,"eighty":-30.148817,"marketCap":11018988687},{"date":"2026-06-05","current":-29.849738,"twenty":-32.359929,"median":-31.257987,"eighty":-30.148817,"marketCap":10223633112},{"date":"2026-06-12","current":-29.369689,"twenty":-32.33377,"median":-30.548005,"eighty":-29.705347,"marketCap":10052410732},{"date":"2026-06-17","current":-30.329435,"twenty":-32.317058,"median":-30.409488,"eighty":-29.732748,"marketCap":10405902098}],"updateTime":1781781190640},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"07630\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2643221934","title":"《大行》高盛列出具有納入南向交易潛力半新股(表)","url":"https://stock-news.laohu8.com/highlight/detail?id=2643221934","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643221934?lang=zh_tw&edition=fundamental","pubTime":"2026-06-15 10:44","pubTimestamp":1781491440,"startTime":"0","endTime":"0","summary":"高盛发表报告，筛选具有纳入南向交易潜力的新上市港股：MiniMax思格能源曦智科技德适生物长光辰芯群核科技深演智能商米科技云迹飞速创新剂泰科技乐动机器人云英谷科技丹诺医药泽景股份瀚天天成华曦达拓璞数控凯乐士科技驭势科技傅里叶首钢朗泽东阳光药天星医疗创想三维天辰生物极视角英派药业华研机器人 爱芯元智瑞博生物HashKey翼菲科技大金重工(港股报价延迟最少十五分钟。沽空资料截至 2026-06-12 16:25。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20251231085225954_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20251231085225954_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1529016/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1529016/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01879","03355","00068","BK1116","01081","BK1109","01609","02526","BK1147","00100","00600","01021","BK1156","BK1179","06636","BK1161","01511","06871","01236","07630","03277","BK1159","06938","06872","BK1163","02729","02670","03625","BK1169","03887","BK1100","01779","BK1144","00901","BK1117","BK1193","BK1137","02632","06887","02723","07688","07666","02553","06810","03388","BK1191","BK1149","03310","06656","02726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106328124","title":"英派藥業-B：6月10日因超額配股權行使發行629.64萬股H股，涉資約1.27億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1106328124","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106328124?lang=zh_tw&edition=fundamental","pubTime":"2026-06-11 06:12","pubTimestamp":1781129528,"startTime":"0","endTime":"0","summary":"2026年6月11日，南京英派药业股份有限公司（英派药业-B，股票代码：07630）发布公告，披露于2026年6月10日因超额配股权获悉数行使，新增发行并配发6,296,400股H股，占发行前已发行股本约2.3%。每股发行价为20.1港元，合计涉资约1.27亿港元。\n本次发行完成后，公司已发行股本由276,165,130股增至282,461,530股。公司确认本次发行已遵循香港联交所证券上市规则及相关法律法规规定，并获得董事会正式授权。上述公告由公司执行董事兼首席执行官蔡遂雄签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"英派药业-B：6月10日因超额配股权行使发行629.64万股H股，涉资约1.27亿港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642471572","title":"英派藥業-B(07630)因超額配股權獲行使而發行629.64萬股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642471572","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642471572?lang=zh_tw&edition=fundamental","pubTime":"2026-06-11 06:10","pubTimestamp":1781129453,"startTime":"0","endTime":"0","summary":"智通财经APP讯，英派药业-B(07630)发布公告，于2026年6月10日因超额配股权获悉数行使而发行及配发629.64万股H股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452889.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641107217","title":"英派藥業-B(07630)：悉數行使超額配股權、穩定價格行動及穩定價格期結束","url":"https://stock-news.laohu8.com/highlight/detail?id=2641107217","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641107217?lang=zh_tw&edition=fundamental","pubTime":"2026-06-08 16:53","pubTimestamp":1780908808,"startTime":"0","endTime":"0","summary":"智通财经APP讯，英派药业-B 发布公告，有关全球发售的稳定价格期于2026年6月7日(星期日)结束。于稳定价格期，稳定价格操作人并无出于稳定价格的目的在市场上购入或出售任何H股。紧随超额配股权获悉数行使及稳定价格期结束后，本公司将继续遵守上市规则第19A.28B条的公众持股量规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451397.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":1}],"pageSize":4,"totalPage":11,"pageCount":1,"totalSize":44,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/07630\",params:#limit:6,delay:false,,,undefined,":[]}}